Background. Prosthetic joint infection in patients with rheumatoid arthritis is a serious complication of total joint arthroplasty. Little information is available on the outcome of medical and surgical treatments of prosthetic joint infection in patients with rheumatoid arthritis.
A total of 5%-7% of patients undergoing total hip or total knee arthroplasty have underlying rheumatoid arthritis [1] . Although selected studies have identified rheumatoid arthritis as a risk factor for prosthetic joint infection (PJI), others have not . Furthermore, patients with rheumatoid arthritis are often treated with immunosuppressive drugs that can potentially increase the risk of PJI [25, 27] . The outcome of rheumatoid arthritis for patients with PJI has not been clearly elucidated, because previously reported cohorts of patients with PJI have included few patients with rheumatoid arthritis [27] [28] [29] [30] . With the use strict case definitions (4) 4 (4) 3 (3) 24 (8, 36) a Includes episodes due to streptococci (2 episodes), unknown pathogens (3), gram-positive bacilli (1) , and other pathogens (1). [31], master diagnostic index [32] , and microbiology laboratory data from 1969-1995.
Patients were excluded from the study if they were !18 years of age at the time of diagnosis of PJI or if they declined to have their medical records reviewed for research. Patients who underwent arthroplasty at the Mayo Clinic were followed up at routine intervals by examination, letter, or telephone conversation. Follow-up occurred twice in the first year after arthroplasty and every 5 years thereafter.
Some of the patients involved in this study were included in previously published reports concerning PJI due to Staphylococcus aureus, coagulase-negative staphylococci, b-hemolytic streptococci, or PJI due to Candida species [28-30, 33, 34] .
DEFINITION OF TERMS
PJI. With use of previously described criteria [28, 30, 33, 34] , PJI was diagnosed if at least 1 of the following was present: isolation of the same microorganism from у2 cultures of joint aspirates or intraoperative tissue specimens, acute inflammation consistent with infection on histopathological examination (as determined by the pathologist), a cutaneous sinus tract communicating with the prosthesis, or purulence in the joint space (as determined by the surgeon).
Treatment failure. Treatment failure was defined as either (1) occurrence of a PJI due to the original microorganism or a different microorganism, the presence of acute inflammation on histopathological examination, or the development of a cutaneous sinus tract communicating with the prosthesis at any time after surgery; (2) death due to prosthesis-related infection; or (3) outside medical reports indicating that the persistence of wound drainage, severe pain, or periprosthetic loosening were present and led to the diagnosis of "infection" outside of our institution, if such a diagnosis was reported by the patient by letter or by telephone.
Rheumatoid arthritis. Rheumatoid arthritis was defined using the American Rheumatism Association criteria [35] .
Synchronous episodes. Synchronous episodes were defined as episodes of PJI occurring in joints other than the index joints and diagnosed within 3 months of the diagnosis of PJI in the index joints.
Joint age. Joint age was defined as the time elapsed between joint arthroplasty and the diagnosis of PJI.
Statistical analysis. Descriptive statistics are reported, giving the number and percentage for discrete variables and the median and 25th and 75th percentiles for continuous variables. The rate of survival free of treatment failure was estimated using the Kaplan-Meier survival method and was reported with 95% CIs [36] . Cox proportional hazards survival method adjusting for correlated data (i.e., multiple joints within a patient) was used to assess risk factors of interest [37] . Hazard ratios (HRs) and 95% CIs are reported from these models. Cox proportional hazards survival method was also used to investigate possible multivariable models. A backwards-elimination method was used that considered all risk factors that had a univariate significance of . However, after the inclusion of surgical P р .20 procedure, no other factors were independently associated with failure at the 5% level of significance. The a-level was set at .05 for statistical significance.
RESULTS

Study population.
A total of 239 episodes of PJI occurred in 161 patients with rheumatoid arthritis between 1 January 1969 and 31 December 1995 at the Mayo Clinic. One patient declined participation in the study. For the purpose of this study, only the first episode of PJI in a given joint was analyzed. Therefore, only 200 incident episodes of PJI in 160 patients occurred during the study period: 125 patients (78%) had a single infected total hip or total knee arthroplasty, 31 (19%) had 2 infected joints, 3 (2%) had 3 infected joints, and 1 (0.5%) had 4 infected joints. The median duration of follow-up for the entire cohort was 5.8 years (range, 1 day to 22.8 years). The median duration of rheumatoid arthritis was 22 years (range, 0.8-66.3 years). The median age at the time of diagnosis of PJI was 62.8 years (range, 23-84 years). Of 200 episodes, a total of 120 (60%) occurred in female patients. A total of 139 (70%) of 200 PJI episodes were total knee arthroplasty infections. In 84 (42%) of the episodes, patients were receiving systemic steroids at the time of diagnosis of PJI. Diabetes mellitus was present in 7 (4%) of the episodes.
Clinical presentation. The median duration between implantation and the diagnosis of PJI was 25 months (range, 9 months to 5 years). The median duration of symptoms prior to diagnosis was 31 days (range, 4-187 days). A temperature of 138.2ЊC or sinus tract were present in 42 (22%) and 67 (33%) of the episodes, respectively. The presence of pus at the time of surgery was found in 110 (55%) of the episodes.
Microbiological findings. The microbiological findings of the 200 episodes of PJI are outlined in table 1. Seventy-four episodes (37%) were due to S. aureus, whereas only 25 (12%) were due to coagulase-negative staphylococci. Of the 116 episodes in which blood cultures were performed, 27 (23%) had microbial growth; 21 (78%) of these 27 episodes were due to S. aureus. Twenty (27%) of 74 episodes of PJI due to S. aureus were bacteremic at the time of diagnosis. Patients with polymicrobial infection and gram-negative bacilli infection had the youngest joint age (table 1) . A significant increase in infection due to gram-positive cocci (S. aureus, coagulase-negative staphylococci, and Enterococcus species) was observed in the last 12 years of the study period (table 1). None of the S. aureus isolates obtained during the study were reported to be resistant to oxacillin.
Surgical therapy. The number of episodes treated with each therapeutic surgical modality is outlined in table 2. The most common surgical intervention was resection arthroplasty without delayed reimplantation, used in 74 (37%) of the 200 episodes. Only 39 (19%) of the episodes were treated with 2-stage exchange. During 1983 and after, more PJI episodes were treated with 2-stage exchange than with debridement and retention of the components, whereas before 1983, more PJI episodes were treated with debridement and retention of the components than with 2-stage exchange (table 2) . Resection arthroplasty without delayed reimplantation was the most common surgical intervention among episodes of PJI due to S. aureus (34 [46%] of 74 episodes). Debridement and retention of components was the most common surgical intervention in NOTE. Data are no. (%) of episodes, unless otherwise indicated. Only data for those episodes treated with the 3 most common surgical therapies for prosthetic joint infection are shown.
episodes involving polymicrobial infections (12 [40%] of 30 episodes).
Medical therapy. The median durations of effective antimicrobial therapy used in resection arthroplasty, 2-stage exchange, and debridement and retention were 29 days (range, 27-37 days), 32 days (range, 25-42 days), and 27 days (range, 21-30 days), respectively. Effective parenteral antimicrobial therapy was determined on the basis of the isolated microorganism and its in vitro sensitivity pattern. b-Lactams and vancomycin were prescribed in 121 (61%) and 14 (7%) of the 200 episodes, respectively. No effective antimicrobial therapy was documented in 8 (4%) of the episodes. Chronic oral antimicrobial therapy was prescribed in 29 episodes. In 26 (90%) of 29 episodes that were treated with chronic oral antimicrobial suppression, the infected prosthesis components were retained. Only 1 patient was treated with a combination of ciprofloxacin and rifampin in this cohort. Therefore, we were unable to analyze the outcome for patients treated with this therapeutic strategy.
Synchronous episodes. Twelve (7%) of 160 patients with rheumatoid arthritis presented with a synchronous infection. Five (42%) of 12 patients with synchronous episodes were receiving steroids at the time of diagnosis. Ten (83%) of 12 synchronous episodes were due to S. aureus; 6 (50%) of 12 patients were bacteremic at the time of PJI diagnosis. Among episodes due to S. aureus, 20 (27%) of 74 were synchronous, whereas only 1 (4%) of 25 episodes due to coagulase-negative staphylococci was synchronous.
Survival analysis. The overall rate of survival free of treatment failure at 5 years for the 200 episodes was 56% (95% CI, 49%-64%). By surgical treatment, the 5-year survival estimates were 32% (95% CI, 21%-49%) for debridement and retention of components, 79% (95% CI, 66%-93%) for 2-stage exchange, and 61% (95% CI, 49%-74%) for resection arthroplasty. The type of surgical procedure was significantly associated with treatment failure. Compared with joints treated with 2-stage exchange, joints treated with debridement and retention had a 5.9-fold increased risk of treatment failure (95% CI, 2.6-13.4-fold;
), joints treated with resection arthroplasty had a P ! .001 2.5-fold increased risk of treatment failure (95% CI, 1.1-5.7-fold;
), and joints treated with other means had a 3.1-P p .03 fold increased risk of treatment failure (95% CI, 1.2-2.7-fold; ) (table 3) . P p .02
In the subgroup of 46 episodes treated with debridement and retention, the 35 episodes with symptom duration of р30 days had a 1-year rate of survival free of treatment failure that was estimated to be 46% (95% CI, 32%-66%), compared with an estimate of 36% (95% CI, 17%-80%) for the 11 episodes with symptom duration of 130 days ( ). In this same P p .94 subgroup of 46 episodes, for the 8 episodes with a joint age р30 days, the 1-year survival rate estimate was 38% (95% CI, 15%-92%), compared with 45% (95% CI, 31%-64%) for the 38 episodes with a joint age of 130 days ( ). P p .63 In a univariate model examining survival free of treatment failure for all 200 episodes, other variables that had a significant association with a worse outcome were the use of long-term immunosuppression (HR, 1.9; 95% CI, 1.0-3.4;
) and P ! .05 episodes with a symptom duration !30 days (HR, 1.6; 95% CI, 1.0-2.6;
). There was a trend toward a worse outcome P ! .05 in episodes involving purulence (HR, 1.4; 95% CI, 0.9-2.3;
) and a trend toward worse outcome according to the P p .10 type of microorganism involved ( ), with the greatest P p .08 increase in risk for those episodes due to a polymicrobial infection, compared with episodes due to a coagulase-negative staphylococci infection (HR, 2.2; 95% CI, 1.2-3.0;
). A P ! .01 multivariable model was assessed; however, once surgical therapy had been accounted for, no other factor was found to be statistically significant ( ). P 1 .05
DISCUSSION
We present, to the best of our knowledge, the largest reported case series of patients with rheumatoid arthritis and PJI. Rheumatoid arthritis can be a chronic and debilitating illness. It may lead to destruction of multiple joints, necessitating multiple joint replacement.
Published case series of PJI in all patients have identified coagulase-negative staphylococci as the most common organism causing PJI [1, 38] . In this large series of patients with rheumatoid arthritis, 37% of PJI episodes were due to S. aureus, and only 12% were due to coagulase-negative staphylococci. The large number of S. aureus infections in this patient population could be explained by the fact that these patients were more likely than other patients to be colonized by S. aureus in their oropharynx or on their skin [39, 40] . A number of these patients has associated keratoconjunctivitis sicca, which includes a decreased salivary flow resulting in xerostomia. This complication results in an altered milieu, including decreased immunoglobulins from the saliva itself, leading to an altered oral flora predisposing patients to S. aureus colonization [39, 40] .
Synchronous infection was present in a significant number of episodes in this cohort, although it was not a risk factor for treatment failure. A high proportion of episodes of PJI due to S. aureus in patients with rheumatoid arthritis involved concomitant bacteremia. This may be because of the fact that bacteremic episodes involving S. aureus are common in this patient population, allowing for potential bacteremic seeding of a joint prosthesis. This would potentially explain why the majority of synchronous episodes were due to S. aureus. The clinician will need to be vigilant about synchronous infection when evaluating patients with multiple-joint arthroplasties and PJI due to S. aureus.
Fifteen percent of patients had a PJI that was caused by 11 microorganism (i.e., a polymicrobial infection). Polymicrobial PJI typically occurs soon after arthroplasty, and in our experience, it is usually associated with the presence of woundhealing complications that allow for a polymicrobial infection to develop by contiguous spread from a superficial surgical site infection. This may be because of the presence of compromised local wound healing as a result of the high proportion of patients receiving long-term therapy with systemic steroids or undergoing prior surgical procedures.
There were more episodes of PJI due to S. aureus, coagulase negative staphylococci, and Enterococcus species in the last 13 years of the study period, compared with the initial 13 years. This increase in the number of infections due to gram-positive bacteria was relative to the number of infections due to aerobic gram-negative bacilli or anaerobes and the number of polymicrobial infections. These secular changes in the microbiology of PJI over a 26-year period parallel the secular changes seen in association with other nosocomial and community-acquired infectious diseases [41] .
The trends in demographic variables associated with specific types of surgical procedures revealed some interesting findings. Patients who were treated with debridement and retention of components had a shorter duration of symptoms, as well as a younger joint age. Several cohort studies have shown that patients with an early PJI or with a short duration of symptoms have a better outcome when treated with this modality [30] . Therefore, orthopedic surgeons are more likely to have been inclined to treat patients with this surgical modality if these variables were present at the time of diagnosis.
The presence of PJI due to S. aureus was associated with a trend towards a worse outcome. This is likely because of the virulence of this organism. Surprisingly, only 19% of patients were treated with 2-stage exchange, which is considered to be the gold standard for both eradicating infection and restoring joint function and is the most common current surgical strategy advocated for treating patients with PJI in the United States [42] . This could be partially explained by the fact that this cohort covered an extended period, beginning in 1969, when 2-stage exchange and current reconstruction techniques for revision surgery were not as sophisticated as they are today. This explanation is supported by our data, which show that 2-stage exchange was more commonly used during the latter part of this study. In addition, other factors, such as reduced bone stock, greater age, multiple operations, and the presence of an infection at another site, might have contributed to the low utilization of this surgical modality.
In this patient population, patients treated with either 2-stage exchange or resection arthroplasty had a better outcome, compared with patients who were treated with debridement and retention of components. This is similar to published data from other cohorts of patients with PJI [38] . Resection arthroplasty, with or without delayed reimplantation, allows for complete eradication of the infection, whereas retention and debridement of the prosthesis does not allow complete eradi-cation of the biofilm present on the prosthesis, explaining the high rate of recurrence associated with this surgical procedure.
Patients undergoing resection arthroplasty without reimplantation had a worse rate of survival free of failure, compared with patients who underwent resection arthroplasty with reimplantation. Similar studies published in the literature have indicated that patients treated with resection arthroplasty have a lower success rate, compared with patients with 2-stage exchange [38] . This may be because of the differences in many characteristics between the 2 groups. Patients undergoing resection arthroplasty without reimplantation tended to be older and to have more S. aureus infections than other patients, and they tended to have more total knee arthroplasty infections than total hip arthroplasty infections (table 4) . Furthermore, patients who had undergone resection without reimplantation were more common during the first part of the study than during the last part of the study (table 2) . Patients who underwent operations during the modern era likely benefitted from improved surgical debridement techniques.
To our knowledge, this is the first published report that has assessed the outcome of PJI for patients with rheumatoid arthritis. Furthermore, this is the first study that has analyzed the outcome associated with various surgical modalities for the same cohort of patients. Nevertheless, this study has several limitations that are inherent to retrospective cohort studies, such as the lack of an established treatment protocol and the inability to assess all potential variables that may have led to differences in treatment outcome. In addition, because this study did not analyze data from patients after 1995, we were unable to assess the effect of TNF-a inhibitors on the microbiological characteristics and outcome of episodes of PJI in patients with rheumatoid arthritis. Therefore, our findings will need to be confirmed by other investigators.
S. aureus is the most common pathogen for patients with rheumatoid arthritis who experience PJI. The surgical modality of 2-stage exchange was used in only 19% of the PJI episodes that occurred in patients with rheumatoid arthritis during the study period, but it was associated with the best outcome. The most important variable that affected the outcome of PJI was the type of surgical modality. Additional studies to determine the reasons for the lack of use of staged exchange as a treatment modality in patients with rheumatoid arthritis who experience PJI are warranted.
